1. Introduction {#s0005}
===============

Colorectal cancer (CRC) testing can prevent mortality ([@bb0125]) but participation in testing is too low ([@bb0100], [@bb0045]). Patients have limited knowledge about need for and benefits of testing ([@bb0040], [@bb0035], [@bb0010]). Physicians\' recommendations are strong predictors of testing ([@bb0075], [@bb0130], [@bb0050], [@bb0070]) but recommendation rates remain suboptimal.

Providers may have difficulty determining what type and schedule of testing is appropriate for patients\' particular risk levels, because family and personal risk factors (e.g., number, size, and histology of polyps or family members\' ages at diagnosis) ([@bb0135]) are not routinely documented in patients\' charts. This may be especially true for patients whose risk levels warrant screening before age 50. There is little information about how many of these younger individuals would benefit from screening, what type they should have, or prevalence of physician recommendations for screening. However, there is reason to believe that screening among younger at-risk individuals is lower than among those over 50. 2010 National Health Interview data showed colonoscopy rate among first-degree relatives ages 40 to 49 (38.3%) was about half of those 50 and older (69.7%) ([@bb0115]). Collecting and evaluating risk information during an office visit can be too time-consuming and complicated ([@bb0015], [@bb0110]) for routine practice.

We developed the *Cancer Risk Intake System* (*CRIS*) --- a touch-screen program that collects data prior to office visits and generates printouts for patients and physicians tailored on: personal and familial risk factors; guideline-based recommendations for test modality, age at initiation, and schedule; and patient concerns about testing. By providing an individually tailored intervention at the point of care delivery, *CRIS* was meant to be a helpful and unobtrusive adjunct to clinical care.

2. Materials and methods {#s0010}
========================

2.1. Overview {#s0015}
-------------

In this cluster-randomized trial, physicians were randomly assigned to receive *CRIS*-tailored printouts outlining patients\' specific risk factors, guideline-based testing options, and concerns about testing, or a standard chart prompt for patients ≥ 50 and not recently screened. Based on assignment of their physicians, patients used *CRIS* and received tailored (n = 329) or non-tailored (n = 322) printouts. To mask the purpose of *CRIS* for the non-tailored comparison group, data collection included questions about multiple cancers, not only CRC. Overall goal of the study was compare screening outcomes between the *CRIS* tailored and non-tailored groups as well as a third group that did not use *CRIS* and received no contact. However, as a mechanism for understanding how the *CRIS* tailored intervention might ultimately increase screening, we also assessed whether it prompted patient-provider discussions. Here we report results from patient telephone surveys conducted with 623 patients from the tailored and non-tailored groups two weeks after the office visit during which they used the *CRIS*. Data were collected by Research Assistants, blinded to participants\' random assignment.

2.2. Setting {#s0020}
------------

The study, approved by the University of Texas Southwestern Medical Center Institutional Review Board and registered on [clinicaltrials.gov](http://clinicaltrials.gov){#ir0005}, enrolled insured patients seen in the general internal medicine faculty clinic and the family medicine faculty clinic at the University of Texas Southwestern (UTSW) Medical Center. A UTSW electronic medical records system administrator developed a query to identify potentially eligible patients with upcoming appointments.

2.3. Eligibility criteria {#s0025}
-------------------------

We sought to enroll patients who were eligible for, but not adherent to, CRC testing based on national guidelines ([@bb0125], [@bb0100], [@bb0055]). We invited patients younger than 50 because *CRIS* algorithms identify those whose risks warrant early testing due to personal history of polyps or inflammatory bowel diseases, or family history of polyps or cancer. For lower age limit, we selected 25 --- the age by which the National Comprehensive Cancer Network at the time of study initiation recommended beginning colonoscopy among carriers of mutations for the Lynch syndrome, the most common hereditary cancer syndrome ([@bb0060]). For patients \< 50, research assistants (RAs) conducted screening during recruitment calls to identify potentially eligible participants with CRC family history, personal history of inflammatory bowel disease, or adenomatous polyps. We asked about these risk factors during this phone screening process because they are not reliably collected and entered into patients\' electronic medical records. We selected 75 as the upper age for inclusion([@bb0120]) and excluded those who had no telephone access and were unable to speak or read English.

2.4. Study design {#s0030}
-----------------

The study has been explained in detail elsewhere ([@bb0085]) and is summarized here. Physician was the unit of random assignment. We used the SAS PROC Plan ([@bb0080]) procedure to randomly assign physicians either to *CRIS*-tailored or non-tailored group using permuted-block randomization with varying block sizes; their patients were therefore pre-identified as *CRIS*-tailored or non-tailored group members before they were invited (Those identified as members of a no-contact control group were, by definition, never contacted and are not included in this report of outcomes from the telephone survey). Identified patients with upcoming appointments (n = 10,216) received letters signed by the clinic medical director saying they "might be invited" for participation in a "study of beliefs and practices about cancer prevention and early detection." After one week during which 96 opted out of contact, research assistants (RAs) called patients to explain the study, verify eligibility and, if patients agreed, arrange in-person meetings 30 min before appointments. Of 2989 potentially eligible patients reached and invited, 1032 agreed to participate and 935 arrived in time to use *CRIS*.

Research Assistants (RA) met patients in the clinic waiting room to obtain consent and facilitate use of the *CRIS* program on a touch-screen tablet computer. After completion, patients gave the tablet back to the RA, who connected it with a printer to generate the printouts. RAs handed the patient\'s printout directly to the patient and placed the physician\'s printout with the patient\'s demographic sheet --- the only piece of paper used for the clinic encounter.

*CRIS* collected demographics, personal history including previous testing, detailed family history, and concerns about testing, then used these data to determine first whether any testing was currently needed. Of the 935 who completed the *CRIS*, 651 were in need of testing. For these, *CRIS* determined risk-appropriate testing option(s) and generated the tailored or non-tailored printouts. RAs conducted telephone interviews with 95.7% (623/651) of participants within 2 weeks of the office visit. Participants received a \$10 gift card for completing the *CRIS* and \$15 for completing the 2-week telephone interview.

2.5. Interventions and measures {#s0035}
-------------------------------

Sample *CRIS*-tailored printouts appear in [Fig. 1](#f0005){ref-type="fig"}. Each includes: summary of patient\'s CRC risks, appropriate test(s) based on self-reported risk factors, and concerns about testing. Consistent with health behavior theory ([@bb0095]), the patient\'s version portrays elevated risk factors with a graphic, includes a statement about testing benefits along with which type of testing is guideline-based, and includes brief messages designed to address concerns. Physicians\' printouts list risk factors, guideline-based testing option(s), and the patient\'s concerns. Because data entered into the program are only as accurate as users\' knowledge and memory, a statement explains the information is based on patient report on the specific date.

Patients in the non-tailored group received text from the *American Cancer Society* brochure (about multiple types of screening) inserted into a format similar to the tailored printouts; their physicians received the UT Southwestern "best practice" electronic prompt for patients 50 and older with no documentation of CRC screening.

To assess topics of discussion during the visit, Research Assistants read: *These next questions are about what you and your doctor talked about during your visit. I*′*ll read a list. You probably didn*\'*t talk about all of these*, *but you may have talked about some. For each please answer yes*, *no*, *or you can*\'*t remember*. They then read the topics shown in [Table 2](#t0010){ref-type="table"}, which lists percentages answering "yes" to each.

2.6. Statistical analysis {#s0040}
-------------------------

To test differences in reported discussions about cancer risk and testing, baseline variables were analyzed using generalized linear mixed models including physician as a random cluster effect. The final analytical sample was 623 patients (n = 314 tailored and n = 309 non-tailored).

3. Results {#s0045}
==========

In the tailored and non-tailored groups, participants were similarly and primarily non-Hispanic White (62% and 67.7%, respectively), and female (62.3% and 67.1%, respectively). See [Table 1](#t0005){ref-type="table"}. In both groups, just over half had at least four years of college (50.2% and 53.1%, respectively). Mean age in tailored group was slightly younger (57.5 v. 59.1 years; *p* = 0.038). Numbers of patients under age 50 who, according to their reported risk factors were due for screening, were similarly small in the tailored (n = 35) and non-tailored (n = 22) groups (10.6% v. 6.8%; *p* = .086) ([@bb0085]). Unemployment was lower in the tailored group (27.1% v. 40.7%, *p* = .0003).

As shown in [Table 2](#t0010){ref-type="table"}, there were significant between-group differences in patient-reported discussions with providers. Tailored recipients were more likely to report discussions about getting cancer (*p* = .004), family history (*p* = .014), and having a stool test (*p* = .011) and colonoscopy (*p* = .025).

4. Conclusions {#s0050}
==============

4.1. Discussion {#s0055}
---------------

Patients in the *CRIS*-tailored group reported more discussion about CRC risk and testing with their physicians during the office visit. The tailored patient printed materials, combined with the tailored physician\'s version (in contrast to only the electronic "best practice" prompt received by physicians in the non-tailored group) may have provided more guidance about topics to discuss during the visit. Particularly robust increases were noted for discussion of family history of cancer, as well as chances of getting cancer.

Discussion alone does not automatically translate into recommendation for or completion of guideline-based testing, but such discussions have been shown to predict participation in screening ([@bb0105]). Recent studies have shown that that use of a narrative interactive computer program about CRC screening before a visit led to more discussion about screening than receipt of a non-tailored brochure ([@bb0025]), and a physician-patient intervention was more effective than a physician-only intervention for increasing rates of CRC screening discussion ([@bb0030]). Findings are also consistent with a previous quasi-experimental (pre-post) pilot test conducted with an earlier version of *CRIS* ([@bb0090]) in which patient-provider discussions increased after *CRIS* and its tailored printouts were introduced into the clinic, compared to before. However, because that study did not compare a tailored v. non-tailored printout, it is only now through the randomized trial that we are able to determine that it was the *tailored* content, rather than the experience of using *CRIS* and receiving *any* printed materials, that seem to have facilitated the discussions.

4.2. Limitations {#s0060}
----------------

Data reported here are limited to the 623 patients who agreed to participate, arrived in time to use *CRIS* for data collection prior to their appointments, and completed the 2-week telephone survey. Outcome for those who, for whatever reason, did not participate when invited, may have differed.

Although previous research has demonstrated reasonable accuracy in reporting family history ([@bb0065]) and CRC screening ([@bb0005]), to the extent that patients were mistaken about *CRIS* responses, accuracy of the resulting guideline recommendations could have been compromised. Our findings are only applicable to patients and physicians receiving reports based on risk factors reported by patients, just prior to an office visit.

The fact that patient-physician discussions were self-reported is also a limitation of our findings. Self-reports, while often assessed in intervention trials ([@bb0095], [@bb0025]), do not always equate with observed discussions ([@bb0020]). Therefore, we can only conclude that more patients in the tailored group perceived and reported discussions than those in the non-tailored group. Also, because the items literally measured self-report of topics *discussed* during the visit, we must note that the reported discussion may or may not have included a screening recommendation.

Finally, data from this trial do not tell us what prompted reported discussions --- tailored information to the patient, the physician, or both? We know that the print outs were given to all patients who used *CRIS* and to physicians in the tailored group but there was likely variation in how much attention each gave to his or her printout. More study is needed to determine the mechanism of action.

5. Conclusion {#s0065}
=============

Patients\' use of *CRIS* and they and their physicians\' receipt of tailored printouts led to more reported discussion about CRC risk and screening than patients receiving a non-tailored print out following *CRIS* use and their physicians getting a standard chart prompt*. CRIS* is a promising strategy for facilitating discussions about risk-based testing in primary-care settings. Programs like *CRIS*, with ability to collect risk information and particular patient concerns, may become increasingly important with the advent of more personalized medicine and inherently complex screening decisions.
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###### 

Baseline patient characteristics by tailored and non-tailored groups.

Table 1

  -------------------------------------------------------------------------------------------------------------------------
                                                Tailored\      Non-tailored\   *p*-Value[a](#tf0005){ref-type="table-fn"}
                                                n = 329\       n = 322\        
                                                n (%)          n (%)           
  --------------------------------------------- -------------- --------------- --------------------------------------------
  Age, mean (± SD)                              57.5 (± 8.6)   59.1 (± 7.9)    0.038

  Race/Ethnicity                                                               0.529

   Hispanic                                     31 (9.4)       26 (8.1)        

   NH White                                     205 (62.3)     218 (67.7)      

   NH Black                                     76 (23.1)      63 (19.6)       

   Asian/Indian/PI                              13 (4.0)       10 (3.1)        

   Other/Refused                                4 (1.2)        5 (1.6)         

  Gender                                                                       0.797

   Female                                       205 (62.3)     216 (67.1)      

   Male                                         124 (37.7)     106 (32.9)      

  Education[b](#tf0010){ref-type="table-fn"}                                   0.452

   \< 4 years of college                        163 (49.5)     151 (46.9)      

   ≥ 4 years of college                         165 (50.2)     171 (53.1)      

  Employment[b](#tf0010){ref-type="table-fn"}                                  0.0003

   Full or part-time                            239 (72.6)     191 (59.3)      

   Unemployed                                   89 (27.1)      131 (40.7)      
  -------------------------------------------------------------------------------------------------------------------------

SD: Standard Deviation; NH: Non-Hispanic; PI: Pacific Islander.

Clinical provider is included as a random cluster effect in the model.

One patient refused education (tailored group); one patient refused employment (tailored group).

###### 

Comparison of patient discussions of cancer risk and testing with their provider.

Table 2

  ---------------------------------------------------------------------------------------------------------------------------
  Discussion topic                  Tailored\   Non-tailored\   Odds ratio\      *p*-Value[a](#tf0015){ref-type="table-fn"}
                                    n = 314\    n = 309\        (95% CI)         
                                    %           %                                
  --------------------------------- ----------- --------------- ---------------- --------------------------------------------
  Chances of getting cancer         27          17              1.9 (1.2--2.9)   0.004

  Family history of cancer          40          25              1.9 (1.1--3.1)   0.014

  Meeting genetic counselor         5           4               1.4 (0.6--3.0)   0.447

  Having a stool blood test         30          21              1.6 (1.1--2.3)   0.011

  Having a flexible sigmoidoscopy   18          15              1.3 (0.8--2.1)   0.307

  Having a colonoscopy              74          66              1.5 (1.0--2.2)   0.025

  Having a CT colonography          9           5               1.8 (0.9--3.4)   0.066

  Having a barium enema             6           4               1.7 (0.8--3.6)   0.177
  ---------------------------------------------------------------------------------------------------------------------------

CI: Confidence interval.

Non-tailored group is the reference group. Clinical provider is included in model as a random cluster effect.
